2 active not recruiting, 2 completed, 2 recruiting, 2 terminated. 8 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Active not recruiting 2, Completed 2, Recruiting 2, Terminated 2 |
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
Follow FMT: new trials by email Literature Review of FMT trials Research Report on FMT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FMT Capsules for rCDI Healthy donor stool, placebo capsule - Clostridioides Difficile Infection Recurrence, FMT | Phase 3 | Recruiting | Helsinki University Central Hospital | 76 | 2026-04-25 | 2026-04-29 |
| Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders FMT, Conventional drugs - Functional Gastrointestinal Disorders | Phase 3 | Terminated | Biao Zou | 47 | 2023-04-03 | 2026-08-03 |
| Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis encapsulated faecal microbiota filtrate, encapsulated faecal microbiota, Placebo - Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 3 | Active not recruiting | Andreas Stallmach | 84 | 2023-01-31 | 2026-08-10 |
| Neurocognitive Effects of FMT in MDD Patients With and Without IBS Fecal Microbiota Transplantation - Major Depressive Disorder, Irritable Bowel Syndrome | Phase 2 / Phase 3 | Active not recruiting | Valerie Taylor | 133 | 2022-04-06 | 2026-03-19 |
| Faecal Microbiota Transplantation for Liver Cirrhosis Faecal microbiota transplantation, Placebo - Liver Cirrhosis | Phase 2 / Phase 3 | Recruiting | University of Aarhus | 220 | 2021-07-01 | 2025-01-24 |
| Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae FMT - Carbapenem-Resistant Enterobacteriaceae Infection | Phase 2 / Phase 3 | Completed | Rambam Health Care Campus | 15 | 2021-04-01 | 2022-10-26 |
| Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae FMT - Carbapenem-Resistant Enterobacteriaceae Infection | Phase 2 / Phase 3 | Completed | Rambam Health Care Campus | 3 | 2020-10-12 | 2022-11-29 |
| Fecal Transplantation for Primary Clostridium Difficile Infection Fecal microbiota transplantation, Vancomycin - Clostridium Difficile Infection | Phase 3 | Terminated | Oslo University Hospital | 104 | 2019-07-17 | 2024-09-19 |
Clostridium Infections (2) · Ascites (1) · Colitis, Ulcerative (1) · Depressive Disorder, Major (1) · Diarrhea (1) · Gastrointestinal Diseases (1) · Gastrointestinal Hemorrhage (1) · Hepatic Encephalopathy (1) · Hepatitis, Alcoholic (1) · Hepatorenal Syndrome (1) · Inflammatory Bowel Diseases (1) · Irritable Bowel Syndrome (1) · Liver Cirrhosis (1)
Rambam Health Care Campus (2) · Andreas Stallmach (1) · Biao Zou (1) · Helsinki University Central Hospital (1) · Oslo University Hospital (1) · University of Aarhus (1) · Valerie Taylor (1)
Israel (2) · Canada (1) · China (1) · Denmark (1) · Finland (1) · Germany (1) · Norway (1)
Andreas Stallmach, Prof. (1) · Haggay Bar Yoseph, MD (1) · Michael Bretthauer, MD, PhD (1) · Michal Paul, MD (1) · Perttu Arkkila, Professor (1) · Valerie Taylor, MD, PhD (1) · Zhihua Huang (1)